Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study

Yukihiro Nakanishi, Atsushi Ochiai, Yuko Yamauchi, Yoshihiro Moriya, Kimio Yoshimura, Setsuo Hirohashi

Research output: Contribution to journalArticlepeer-review

58 Citations (Scopus)


There is no unanimity about the prognostic significance of lymph node micrometastases from colorectal cancer. A case-control study of patients with recurrent and nonrecurrent colorectal cancer who were closely matched for the Dukes stage, extent of lymph node dissection, tumor size, tumor location, number of resected lymph nodes, age and gender was performed. The presence of micrometastases in a total of 1633 lymph nodes from 44 patients (22 with and 22 without recurrence) were examined by immunohistochemistry using antibodies for cytokeratin (KL-1) and p53 (RSP53). Immunostaining with KL-1 revealed micrometastases in 15/22 patients [68%; 82/820 lymph nodes (10%)] and 15/22 patients [68%; 45/813 lymph nodes (6%)] in the recurrent and nonrecurrent groups, respectively. Immunohistochemical analysis, using RSP53, of 18 paired patients with p53-positive primary tumor revealed micrometastases in 4/9 patients [44%; (7/265 lymph nodes (2.6%)] and 4/9 patients [44%; 6/257 lymph nodes (2.3%)] with and without recurrence, respectively. Neither the micrometastatic frequencies of the patients nor the resected lymph nodes of the recurrent and nonrecurrent groups differed significantly. Micrometastases in regional lymph nodes are an interesting phenomenon, but do not influence patients' prognoses if the involved lymph nodes are removed.

Original languageEnglish
Pages (from-to)276-280
Number of pages5
Issue number4
Publication statusPublished - 1999 Nov
Externally publishedYes


  • Case-control study
  • Colorectal cancer
  • Immunohistochemistry
  • Micrometastasis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study'. Together they form a unique fingerprint.

Cite this